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Student Researches Alzheimer-like Deficiencies in Rats 
BLOOMINGTON, Ill. – Illinois Wesleyan University student Andrew Tharp and Renee 
Countryman, assistant professor of psychology, have been conducting research related to newer 
pharmaceutical treatments for Alzheimer’s disease. 
Tharp, a senior psychology major from Lake in the Hills, Ill., and Countryman are 
studying the effects of the drug Guanfacine on rats with induced memory deficiencies similar to 
Alzheimer’s. 
Alzheimer’s disease, a brain disorder that usually affects people age 65 and older, causes 
memory loss and behavioral issues associated with dementia. 
A known cause of Alzheimer’s symptoms is a decrease of acetylcholine in the brain. 
Acetylcholine, a chemical neurotransmitter, carries messages between neurons and other cells. In 
order to mimic this condition in rats Tharp and Countryman administered a drug that decreases 
acetylcholine thereby affecting the rats’ memory. 
 According to Countryman, current drugs are designed to increase the level of 
acetylcholine in the brain by inhibiting an enzyme that normally functions to destroy any excess 
amounts of acetylcholine. However, as Alzheimer's disease progresses, acetylcholine naturally 
becomes less available in the brain. Drugs that inhibit this enzyme eventually become ineffective 
when there is little or no acetylcholine left to prevent from being destroyed. 
 “The problem is Alzheimer’s treatments just don’t work for humans in the long-term, 
they may work for a short period, but they always stop working over time,” says Countryman. 
 The drug that Tharp and Countryman are studying, however, takes a different approach to 
improving memory loss by focusing on a different neurotransmitter. Guanfacine increases the 
levels of the neurotransmitter norepinephrine, associated with attention and awareness. By 
increasing norepinephrine levels in the brain, the drug boosts attention and awareness thereby 
enhancing perceptions and hopefully improving memory. 
 “We can see how this idea works using college students as an example. If a student 
comes to class awake and pays attention he retains more information than a student who shows 
up and does not focus on the lecture,” says Countryman. 
NEWS RELEASE 
NOTE TO MEDIA: To receive this release electronically, e-mail univcomm@titan.iwu.edu or visit www.iwu.edu/~iwunews 
 
 Current results from Tharp and Countryman’s study show that Guanfacine may be 
effective at improving memory impairments caused by decreased acetylcholine function as seen 
in Alzheimer’s disease. 
 Tharp will present the research in the poster session of IWU’s John Wesley Powell 
Conference on April 12. He will also present at the Midwestern Psychological Association – Psi 
Chi Conference in Chicago, Ill. on May 1. 
 For additional information, contact the Office of University Communications at (309) 
556-3181.  
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